Ichor Holdings, Ltd.
ICHR Nasdaq Semiconductors & Related Devices Financials FY2016βFY2025
What Ichor Holdings, Ltd. does
No business description yet.
- Legal name
- ICHOR HOLDINGS, LTD.
- Fiscal year ends
- December 26, 2025
- Latest annual report
- 10-K Β· Feb 20, 2026
- Accession Β· CIK
- 0001652535-26-000012
0001652535
Revenue and margins
Ichor Holdings, Ltd. had $948M of revenue in fiscal 2025, up 11.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$6.3M in fiscal 2025, β0.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ichor Holdings, Ltd. returned β to shareholders in fiscal 2025. The diluted share count rose 4.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Ichor Holdings, Ltd. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $75.5M | $86.5M | $80.0M | $109M | $98.3M |
| Debt incl. finance leases | $293M | $301M | $249M | $129M | $124M |
| Net debt / EBITDA | 2.0x | 1.8x | 7.1x | 0.9x | β |
| Debt / equity | 0.6x | 0.5x | 0.4x | 0.2x | 0.2x |
| Interest coverage | 12.6x | 7.8x | β0.6x | β0.8x | β5.9x |
| Current ratio | 2.2x | 3.1x | 4.1x | 3.3x | 3.2x |
| Quick ratio | 1.1x | 1.4x | 1.6x | 1.5x | 1.4x |
| Total assets | $1.0B | $1.1B | $938M | $996M | $943M |
| Total liabilities | $520M | $496M | $374M | $297M | $279M |
| Shareholders' equity | $501M | $587M | $565M | $698M | $664M |
| Net debt (β = net cash) | $217M | $214M | $169M | $19.9M | $25.2M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 8 / 9 | 5 / 9 | 7 / 9 | 4 / 9 | 7 / 9 | 4 / 9 | 4 / 9 | 3 / 9 |
| Accruals ratio | β3.9% | 4.2% | β0.5% | β8.8% | β0.7% | 6.2% | 3.9% | β10.0% | β5.0% | β8.5% |
| Altman Z'' | 2.30 | 2.78 | 3.69 | 2.57 | 4.82 | 3.74 | 4.62 | 4.33 | 5.11 | 4.62 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $406M | $656M | $824M | $621M | $914M | $1.1B | $1.3B | $811M | $849M | $948M |
| Gross profit | $65.4M | $101M | $136M | $86.4M | $125M | $177M | $212M | $103M | $103M | $87.8M |
| Research and development | $6.4M | $7.9M | $9.4M | $11.1M | $13.4M | $15.7M | $19.6M | $20.2M | $23.0M | $23.1M |
| Operating income | $23.9M | $46.2M | $64.0M | $15.0M | $41.6M | $81.0M | $85.8M | β$10.9M | β$7.6M | β$39.3M |
| Interest expense | $4.4M | $3.3M | $10.0M | $10.6M | $8.7M | $6.5M | $11.1M | $19.4M | $9.3M | $6.6M |
| Pretax income | $20.1M | $43.0M | $54.2M | $4.3M | $32.3M | $73.8M | $75.3M | β$31.1M | β$18.1M | β$47.6M |
| Income tax | β$0.6M | β$13.9M | β$3.7M | β$6.5M | β$1.0M | $2.9M | $2.5M | $11.9M | $2.8M | $5.2M |
| Net income | $16.7M | $56.5M | $57.9M | $10.7M | $33.3M | $70.9M | $72.8M | β$43.0M | β$20.8M | β$52.8M |
| Net income to common | $1.7M | $56.9M | $57.9M | β | β | β | β | β | β | β |
| Diluted EPS | $0.70 | $2.15 | $2.30 | $0.47 | $1.42 | $2.45 | $2.51 | β$1.47 | β$0.64 | β$1.54 |
| Diluted shares | 0.00B | 0.03B | 0.03B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $27.7M | $38.8M | $60.5M | $57.2M | $38.3M | $15.3M | $31.5M | $57.6M | $27.9M | $29.9M |
| Capital expenditure | $4.3M | $8.2M | $13.9M | $12.3M | $10.3M | $20.8M | $29.4M | $15.5M | $17.6M | $36.2M |
| Free cash flow | $23.5M | $30.6M | $46.6M | $44.8M | $28.0M | β$5.6M | $2.0M | $42.1M | $10.2M | β$6.3M |
| Depreciation and amortization | $9.5M | $12.5M | $23.1M | $21.9M | $24.2M | $26.0M | $35.1M | $34.6M | $30.7M | $33.5M |
| Stock-based compensation | $3.2M | $2.2M | $7.6M | $8.5M | $9.9M | $11.5M | $13.9M | $17.3M | $15.6M | $16.7M |
| Acquisitions | $17.4M | $181M | $1.4M | β | $5.0M | $269M | β$0.5M | $0.0M | $0.0M | β |
| Share buybacks | β | β | $90.0M | $1.6M | β | β | β | β | β | β |
| Dividends and buybacks | β | β | $90.0M | $1.6M | β | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $52.6M | $69.3M | $43.8M | $60.6M | $253M | $75.5M | $86.5M | $80.0M | $109M | $98.3M |
| Total debt | $37.9M | $187M | $201M | $178M | $200M | $293M | $301M | $249M | $129M | $124M |
| Current assets | $157M | $278M | $212M | $277M | $496M | $463M | $513M | $401M | $453M | $410M |
| Current liabilities | $101M | $147M | $87.8M | $164M | $162M | $208M | $166M | $99.0M | $136M | $130M |
| Inventory | $70.9M | $155M | $121M | $127M | $135M | $236M | $284M | $246M | $250M | $232M |
| Property and equipment, net | $12.0M | $34.4M | $41.7M | $44.5M | $41.8M | $85.2M | $98.1M | $92.8M | $94.9M | $104M |
| Goodwill | $77.1M | $169M | $173M | $173M | $175M | $336M | $335M | $335M | $335M | $335M |
| Intangible assets | $32.1M | $73.4M | $56.9M | $52.0M | $39.8M | $89.9M | $72.0M | $57.3M | $48.7M | $40.4M |
| Total assets | $282M | $558M | $485M | $567M | $774M | $1.0B | $1.1B | $938M | $996M | $943M |
| Total liabilities | $141M | $341M | $287M | $345M | $362M | $520M | $496M | $374M | $297M | $279M |
| Preferred stock | β | β | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $142M | $217M | $198M | $221M | $412M | $501M | $587M | $565M | $698M | $664M |
| Margins | ||||||||||
| Gross margin | 16.1% | 15.4% | 16.5% | 13.9% | 13.7% | 16.2% | 16.6% | 12.7% | 12.2% | 9.3% |
| Operating margin | 5.9% | 7.0% | 7.8% | 2.4% | 4.5% | 7.4% | 6.7% | β1.3% | β0.9% | β4.1% |
| EBITDA margin | 8.2% | 8.9% | 10.6% | 5.9% | 7.2% | 9.8% | 9.4% | 2.9% | 2.7% | β0.6% |
| Net margin | 4.1% | 8.6% | 7.0% | 1.7% | 3.6% | 6.5% | 5.7% | β5.3% | β2.5% | β5.6% |
| FCF margin | 5.8% | 4.7% | 5.7% | 7.2% | 3.1% | β0.5% | 0.2% | 5.2% | 1.2% | β0.7% |
| Returns | ||||||||||
| Return on capital | 18.8% | 13.8% | 18.0% | 4.4% | 11.6% | 10.8% | 10.3% | β1.2% | β0.8% | β4.5% |
| Return on capital employed | 13.2% | 11.3% | 16.1% | 3.7% | 6.8% | 10.0% | 9.4% | β1.3% | β0.9% | β4.8% |
| Return on equity | 11.8% | 31.5% | 27.9% | 5.1% | 10.5% | 15.5% | 13.4% | β7.5% | β3.3% | β7.7% |
| Return on assets | 5.9% | 13.4% | 11.1% | 2.0% | 5.0% | 7.9% | 6.9% | β4.3% | β2.2% | β5.4% |
| Return on tangible equity | 5.3% | β | β | β | 16.9% | 94.7% | 40.4% | β25.0% | β6.6% | β18.3% |
| Growth | ||||||||||
| Revenue growth | β | 61.7% | 25.6% | β24.6% | 47.3% | 20.0% | 16.7% | β36.6% | 4.7% | 11.6% |
| Net income growth | β | 238.8% | 2.5% | β81.5% | 210.2% | 113.0% | 2.7% | β159.0% | β | β |
| EPS growth | β | 207.1% | 7.0% | β79.6% | 202.1% | 72.5% | 2.4% | β158.6% | β | β |
| FCF growth | β | 30.3% | 52.3% | β3.8% | β37.6% | β119.9% | β | 1,985.9% | β75.7% | β161.3% |
| Share count change | β | 1,232.3% | β4.2% | β9.4% | 3.0% | 23.5% | β0.1% | 0.8% | 12.2% | 4.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.4x | 2.0x | 1.8x | 3.2x | β0.8x | 2.0x | 1.8x | 7.1x | 0.9x | β |
| Debt / equity | 0.3x | 0.9x | 1.0x | 0.8x | 0.5x | 0.6x | 0.5x | 0.4x | 0.2x | 0.2x |
| Interest coverage | 5.5x | 14.1x | 6.4x | 1.4x | 4.8x | 12.6x | 7.8x | β0.6x | β0.8x | β5.9x |
| Current ratio | 1.6x | 1.9x | 2.4x | 1.7x | 3.1x | 2.2x | 3.1x | 4.1x | 3.3x | 3.2x |
| Quick ratio | 0.9x | 0.8x | 1.0x | 0.9x | 2.2x | 1.1x | 1.4x | 1.6x | 1.5x | 1.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 1.3% | 1.7% | 2.0% | 1.1% | 1.9% | 2.3% | 1.9% | 2.1% | 3.8% |
| Stock comp / revenue | 0.8% | 0.3% | 0.9% | 1.4% | 1.1% | 1.0% | 1.1% | 2.1% | 1.8% | 1.8% |
| Payouts / FCF | β | β | 193.3% | 3.6% | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 8.0 | 5.0 | 7.0 | 4.0 | 7.0 | 4.0 | 4.0 | 3.0 |
| Altman Z'' | 2.3 | 2.8 | 3.7 | 2.6 | 4.8 | 3.7 | 4.6 | 4.3 | 5.1 | 4.6 |
| Accruals ratio | β3.9% | 4.2% | β0.5% | β8.8% | β0.7% | 6.2% | 3.9% | β10.0% | β5.0% | β8.5% |
Source: SEC EDGAR XBRL filings (CIK 0001652535). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.